Scarica l'app Stockscreener
15.68
0.77%
0.12
Q 32 Bio Inc Borsa (QTTB) Ultime notizie
H.C. Wainwright raises Q32 Bio stock price target to $36 on alopecia drug outlook - Investing.com
Q32 Bio Inc (QTTB) Balance Sheet - TradingKey
Q32 Bio Inc (QTTB) Income Statement - TradingKey
Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Q32 Bio Inc (QTTB) Cash Flow - TradingKey
QTTB|Q32 Bio Inc|Price:15.060|Chg%:-0.150 - TradingKey
QTTB|Q32 Bio Inc|Price:15.140|Chg%:-0.010 - TradingKey
Q32 Bio Inc (QTTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Q32 Bio Inc (QTTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Q32 Bio Inc (QTTB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Q32 Bio Inc (QTTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Q32 Bio Inc (QTTB) Institutional Confidence - TradingKey
Q32 Bio Inc. (QTTB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q32 Bio Inc (NASDAQ: QTTB) Stock Price, News & Analysis - Kalkine
Q32 Bio Inc Revenue Breakdown – DUS:DB0 - TradingView
Q32 Bio Inc (QTTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Q32 Bio (QTTB) awards 10,826 stock options to director - Stock Titan
Q32 Bio (QTTB) corrects director’s 10,826 stock option award in Form 4/A - Stock Titan
Stock option grant for Q32 Bio Inc. (QTTB) director corrects prior award - Stock Titan
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 4 Q32 Bio Inc For: 21 July By Investing.com - Investing.com Canada
Form 13D/A Q32 Bio Inc. For: 21 July By Investing.com - Investing.com Canada
OrbiMed reports 13.9% Q32 Bio ownership and 45-day lock-up (QTTB) - Stock Titan
Are You Looking for a Top Momentum Pick? Why Q32 Bio (QTTB) is a Great Choice - Yahoo Finance
Form S-3 Q32 Bio Inc For: 17 July By Investing.com - Investing.com Canada
Q32 Bio files prospectus for offer and resale of 6.875M shares - scanx.trade
Q32 Bio (Nasdaq: QTTB) files to register 6.9M shares for resale - Stock Titan
Q32 Bio: Bempikibart's Progress Keeps Me Bullish (NASDAQ:QTTB) - Seeking Alpha
Boxer Capital Management, LLC Acquires Significant Stake in Q32 Bio Inc - GuruFocus
Why is Q32 Bio stock falling Wednesday? - MSN
Q32 Bio Inc. Announces $300 Million Public Offering of Common Stock and Pre-Funded Warrants – Underwriting Agreement Details and Legal Opinions Included – Minichart - Minichart
Form 424B5 Q32 Bio Inc For: 15 July By Investing.com - Investing.com Nigeria
Q32 Bio Enters Underwriting for $18.25 Offering, Net Proceeds ~$188M; Option Lifts to ~$216M - TradingView
Q32 Bio (Nasdaq: QTTB) raises $187.6M in stock and pre-funded warrant deal - Stock Titan
Ericsson, Q32 Bio and other big stocks moving lower in Tuesday’s pre-market session - MSN
Why Is Q32 Bio Stock Falling Wednesday? - Benzinga
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
Q32 Bio prices $200M public offering, shares fall - scanx.trade
Q32 Bio Prices $200 Million Share Sale to Accelerate Alopecia Areata Drug Development - finance.biggo.com
Q32 Bio prices $200M public offering to fund al... - Pluang
Q32 Bio Expects $200M Offering to Support Bempikibart Trials - Stock Titan
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants - PR Newswire
$100 Invested In Q32 Bio 5 Years Ago Would Be Worth This Much Today - Benzinga
Q32 Bio Reports Positive Phase 2a Results for Bempikibart in Severe Alopecia Areata, Plans Pivotal Programme - BioPharma APAC
Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Sahm
Q32 Bio (QTTB) After Positive Trial Data Is It A Buy Or Already Fairly Valued - Yahoo Finance
Q32 Bio delivers 23.91% average annual return over five years - scanx.trade
Mizuho raises Q32 Bio stock price target on alopecia drug data - Investing.com UK
Why Q32 Bio Stock Skyrocketed Today - The Motley Fool
Q32 Bio reports positive bempikibart trial data in alopecia areata - scanx.trade
Q32’s bempikibart starts to differentiate from JAK inhibitors in alopecia - BioCentury
Form 424B5 Q32 Bio Inc For: 13 July By Investing.com - Investing.com Nigeria
Form 424B5 Q32 Bio Inc For: 13 July - Investing.com UK
Q32 Bio: 'Strong Buy' On Solid Bempikibart SIGNAL-AA Study Data And Catalysts - Seeking Alpha
Biotech Q32 Bio moves to raise $200M for alopecia and autoimmune drug work - Stock Titan
Mizuho raises Q32 Bio stock price target on alopecia drug data By Investing.com - Investing.com Australia
Oppenheimer raises Q32 Bio stock price target on trial data to $40 - Investing.com UK
Q32 Bio Reports Positive Phase 2a Alopecia Areata Results - TipRanks
Q32 Bio’s Bempikibart Shows Durable Hair Regrowth in Phase 2 Alopecia Study - TradingView
Q32 Bio’s Bempikibart Shows Robust 36-Week Efficacy and Safety in Severe Alopecia Areata Phase 2a SIGNAL-AA Trial Results – Minichart - Minichart
JAKs or better: Q32 ups ante in AA with IL-7 antibody phase II - BioWorld News
There are notable gap-ups and gap-downs in today's session. - ChartMill
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):